Completed PHASE2 INTERVENTIONAL 2-arm NCT00848315

Diabetes Management in Low-Income Hispanic Patients

Sponsor: University of Massachusetts, Worcester

Conditions Glycemic Control Type 2 Diabetes

Interventions Cognitive Behavioral Intervention

Updated 5 times since 2017 Last updated: Sep 11, 2023 Started: Jul 31, 2004 Primary completion: Jun 30, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00848315, this PHASE2 trial focuses on Glycemic Control and Type 2 Diabetes and remains completed. Sponsored by University of Massachusetts, Worcester, it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Oct 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Oct 2023 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Massachusetts, Worcester

Data source: University of Massachusetts, Worcester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Springfield, United States
• Worcester, United States